| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.98B | +22.4% |
| Cost of Revenue | $2.29B | +19.1% |
| Gross Profit | $8.70B | +23.4% |
| R&D Expense | $2.54B | +19.7% |
| SG&A Expense | $936.0M | +8.5% |
| Operating Income | $1.36B | +79.0% |
| Pre-tax Income | $1.74B | +72.4% |
| Income Tax | $313.0M | +143.3% |
| Net Income | $1.43B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.30B | +21.5% |
| Accounts Receivable | $2.24B | +10.0% |
| Current Assets | $9.19B | +18.1% |
| Total Assets | $20.38B | +17.2% |
| Current Liabilities | $8.36B | +13.5% |
| Total Liabilities | $10.77B | +10.4% |
| Stockholders' Equity | $9.61B | +26.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.27B | +25.6% |
| Capital Expenditures | $852.0M | +22.8% |
| Investing Cash Flow | -$2.50B | -15.4% |
| Financing Cash Flow | -$1.34B | -67.2% |
| Free Cash Flow | $3.42B | +26.3% |
| -17.7% |
| EPS (Basic) | $6.92 | -18.4% |
| EPS (Diluted) | $6.84 | -18.8% |